Lai Andrew, Dobbs Ryan W, Talamini Susan, Halgrimson Whitney R, Wilson Jessica O, Vigneswaran Hari T, Crivellaro Simone
Department of Urology, University of Illinois at Chicago, Chicago, IL, USA.
Transl Androl Urol. 2020 Apr;9(2):898-905. doi: 10.21037/tau.2019.11.05.
Several studies have assessed the safety and feasibility of single port robot-assisted radical prostatectomy using different and custom built robotic-assisted technology. In part due to the non-standardized nature of these approaches, single site robotic prostatectomy has not been widely adopted. With the recent approval of the da Vinci (Intuitive Surgical, Sunnyvale CA) Single Port (SP) platform, there has been a renewed interest in single site robotic-assisted prostatectomy and several institutions have begun reporting their initial experiences with this technique. In this systematic review, we sought to assess and summarize the literature regarding patient outcomes for single site robotic-assisted prostatectomy and evaluate its role in surgical treatment of prostate cancer. This systematic review was structured using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies describing the use of any robotic platform, including da Vinci Si, Xi or SP platforms for robotic single-port or single site radical prostatectomy between 2000 and July 15, 2019 were eligible for inclusion in this systematic review. Studies were excluded if they included combined cases with other organ resection, represented use in a non-clinical setting (such as a cadaveric model), or described results for a simple prostatectomy technique. Data was extracted by two authors with concerns resolved by consensus. Primary outcomes were mean operative times, estimated blood loss (mL), and hospital length of stay (days). Secondary outcomes included intraoperative conversion to open surgery, and intraoperative and postoperative complications. Variables of interest included sample size (n), mean age (years), mean prostate size (mL), prostate specific antigen (PSA, ng/mL), Gleason score, clinical and pathological TNM staging [American Joint Commission on Cancer (AJCC)], lymph nodes (n) and perioperative complications as available. A total of 217 studies were reviewed by title and abstract, with 28 selected for full-text review; ultimately, 12 studies were included, with available data from 145 patients. Primary outcomes and preoperative characteristics varied greatly amongst patients and across studies. One patient (0.7%) required conversion to a multi-port approach and there were no conversions to an open technique. No intraoperative complications were reported, and no Clavien grade III or greater postoperative complications have been described in the initial 81 radical prostatectomies performed with the SP platform. Single Port techniques appear to represent a safe and feasible approach for performing the minimally invasive radical prostatectomy. The current available literature on the single port radical prostatectomy is weak and consists of single center studies with small sample sizes, short-term follow up and limited functional data. More rigorous multi-center trials with standardized metrics for reporting functional outcomes as well as long-term cancer specific survival are necessary to validate these initial studies.
多项研究评估了使用不同的定制机器人辅助技术进行单孔机器人辅助根治性前列腺切除术的安全性和可行性。部分由于这些方法的非标准化性质,单部位机器人前列腺切除术尚未得到广泛应用。随着达芬奇(直观外科公司,加利福尼亚州森尼韦尔)单孔(SP)平台最近获得批准,人们对单部位机器人辅助前列腺切除术重新产生了兴趣,一些机构已开始报告他们使用该技术的初步经验。在本系统评价中,我们试图评估和总结关于单部位机器人辅助前列腺切除术患者预后的文献,并评估其在前列腺癌手术治疗中的作用。本系统评价按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行构建。描述在2000年至2019年7月15日期间使用任何机器人平台(包括达芬奇Si、Xi或SP平台)进行机器人单孔或单部位根治性前列腺切除术的研究有资格纳入本系统评价。如果研究包括与其他器官切除术的联合病例、代表在非临床环境(如尸体模型)中的使用或描述简单前列腺切除术技术的结果,则将其排除。数据由两名作者提取,如有分歧通过共识解决。主要结局为平均手术时间、估计失血量(mL)和住院时间(天)。次要结局包括术中转为开放手术以及术中及术后并发症。感兴趣的变量包括样本量(n)、平均年龄(岁)、平均前列腺体积(mL)、前列腺特异性抗原(PSA,ng/mL)、Gleason评分、临床和病理TNM分期[美国癌症联合委员会(AJCC)]、淋巴结(n)以及可获得的围手术期并发症。通过标题和摘要共检索了217项研究,其中28项被选进行全文审查;最终,纳入了12项研究,有145例患者的可用数据。主要结局和术前特征在患者之间以及不同研究中差异很大。1例患者(0.7%)需要转为多孔手术方法,且没有转为开放技术的情况。未报告术中并发症,在最初使用SP平台进行的81例根治性前列腺切除术中,也未描述Clavien III级或更高级别的术后并发症。单孔技术似乎是一种安全可行的进行微创根治性前列腺切除术的方法。目前关于单孔根治性前列腺切除术的现有文献证据不足,包括单中心研究,样本量小、随访时间短且功能数据有限。需要更严格的多中心试验,采用标准化指标报告功能结局以及长期癌症特异性生存率,以验证这些初步研究。